Level 6/8 Help St, Chatswood NSW 2067Registered from 27 Nov 2024

contact@uriahinvestment.com.au+61 430 166 639

Concentrated equity reduction

Single-issuer exposure above 45% of net worth following a corporate acquisition and share vesting schedule.

Concentrated equity reduction — illustrative photograph
Client type: ExecutiveDuration: 14 months

Problem

The client’s wealth was dominated by listed shares in one acquirer after a merger, with additional unvested rights creating future concentration. Emotional attachment to the company story conflicted with IPS limits (20% single-issuer cap). Prior advisers had suggested immediate liquidation; the client resisted, fearing regret if the stock re-rated. Tax on large gains was material and had not been modelled against charitable intentions.

Portfolio allocation review on desk
Advisers reviewing a concentrated equity holding

Solution design

We built a staged divestment plan tied to vesting dates and liquidity windows, with tranches sold when the issuer traded inside pre-agreed valuation bands. Each tranche required pre-clearance against remaining concentration and tax budget. Parallel diversification into broad Australian and global index exposures reduced issuer beta without pretending to eliminate it overnight.

Controls

  • Weekly concentration dashboard vs 20% cap path.
  • Written exception process if issuer fell more than 25% in a month.
  • Charitable giving model reviewed with tax adviser before year-end.

Results

Issuer weight fell from 47% to 22% over fourteen months without a single panic sale. The client retained a defined “legacy lot” within IPS for sentimental exposure. Documented plan reduced conflict in family discussions about risk. No guarantee other concentrations will behave similarly.

Request proposal

Questions about this concentrated equity

Why stage sales instead of one liquidation?
Tax, behaviour, and regret risk often favour tranches tied to valuation bands and vesting dates rather than a single exit.
What is a legacy lot?
A defined portion of issuer exposure retained within IPS for sentimental or strategic reasons, with the remainder on a reduction path.
How are IPS breaches handled?
Weekly concentration dashboards and written exception processes—not ad hoc phone instructions.
Are these results typical?
No. Outcomes depend on issuer performance, tax, and client decisions. The case includes explicit non-guarantee language.

Illustrative process comment—not a verified review or performance claim.

“Staging sales against vesting dates made the reduction path discussable with family—without a single ‘sell everything’ ultimatum.”
Illustrative · executive shareholder scenario